SEARCH

SEARCH BY CITATION

References

  • 1
    Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 129.
  • 2
    Ault KA. Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials. Lancet 2007; 369: 18618.
  • 3
    Garland SM, Hernandez-Avila M, Wheeler CM, Perez G, Harper DM, Leodolter S, Tang GW, Ferris DG, Steben M, Bryan J, Taddeo FJ, Railkar R, et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 2007; 356: 192843.
  • 4
    Paavonen J, Jenkins D, Bosch FX, Naud P, Salmeron J, Wheeler CM, Chow SN, Apter DL, Kitchener HC, Castellsague X, de Carvalho NS, Skinner SR, et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet 2007; 369: 216170.
  • 5
    Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER; Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP). Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007; 56( RR-2): 126.
  • 6
  • 7
    Ministère de la Santé de la Jeunesse de sports et de la Via associative, France. Nouvelles recommendations. Available at: http://www.sante-jeunesse-sports.gouv.fr/dossiers/sante/vaccinations-vaccins- politique-vaccinale/calendrier-vaccinal-2008/calendrier-vaccinal-detaille-2008. html?var_recherche=vaccination, Accessed September, 2008.
  • 8
    Australian Government. Department of Health and Ageing. Announcement for the Human papillomavirus (HPV) vaccination program. Available at: http://www.health.gov.au/internet/immunise/ publishing.nsf/Content/hpv-vac-prog. Accessed August, 2006.
  • 9
    Ministry of Health in New Zealand. Information on HPV Immunisation Programme—the facts. Available at: http://www.moh.govt.nz/moh.nsf/indexmh/ hpv-immunisation-programme- facts-4aug08. Accessed August 2008.
  • 10
    National Board of Health, Denmark. Available at: http://www.sst.dk/Nyheder/Seneste_nyheder/HPV_vaccination_ september2008.aspx?lang =da. Accessed September, 2008.
  • 11
    The Swedish National Board of Health and Welfare, Sweden Recommendations. Available at: http://www.socialstyrelsen.se/Publicerat/2008/10201/2008-130-12.htm. Accessed November 2008.
  • 12
    Zimet GD, Perkins SM, Sturm LA, Bair RM, Juliar BE, Mays RM. Predictors of STI vaccine acceptability among parents and their adolescent children. J Adolesc Health 2005; 37: 17986.
  • 13
    Brabin L, Roberts SA, Farzaneh F, Kitchener HC. Future acceptance of adolescent human papillomavirus vaccination: a survey of parental attitudes. Vaccine 2006; 24: 308794.
  • 14
    Lenselink CH, Gerrits MM, Melchers WJ, Massuger LF, van Hamont D, Bekkers RL. Parental acceptance of human papillomavirus vaccines. Eur J Obstet Gynecol Reprod Biol 2008; 137: 1037.
  • 15
    Lazcano-Ponce E, Rivera L, Arillo-Santillan E, Salmeron J, Hernandez-Avila M, Munoz N. Acceptability of a human papillomavirus (HPV) trial vaccine among mothers of adolescents in Cuernavaca, Mexico. Arch Med Res 2001; 32: 2437.
  • 16
    Bair RM, Mays RM, Sturm LA, Zimet GD. Acceptability of the human papillomavirus vaccine among Latina mothers. J Pediatr Adolesc Gynecol 2008; 21: 32934.
  • 17
    Centers for Disease Control and Prevention (CDC). Vaccination coverage among adolescents aged 13–17 years — United States, 2007. MMWR Morb Mortal Wkly Rep 2008; 57: 110003.
  • 18
    Marlow LA, Waller J, Wardle J. Parental attitudes to pre-pubertal HPV vaccination. Vaccine 2007; 25: 194552.
  • 19
    Walsh CD, Gera A, Shah M, Sharma A, Powell JE, Wilson S. Public knowledge and attitudes towards human papilloma virus (HPV) vaccination. BMC Public Health 2008; 8: 368.
  • 20
    Slomovitz BM, Sun CC, Frumovitz M, Soliman PT, Schmeler KM, Pearson HC, Berenson A, Ramirez PT, Lu KH, Bodurka DC. Are women ready for the HPV vaccine? Gynecol Oncol 2006; 103: 1514.
  • 21
    Kahn JA, Rosenthal SL, Hamann T, Bernstein DI. Attitudes about human papillomavirus vaccine in young women. Int J STD AIDS 2003; 14: 3006.
  • 22
    Dempsey AF, Zimet GD, Davis RL, Koutsky L. Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV. Pediatrics 2006; 117: 148693.
  • 23
    Rosenthal SL, Rupp R, Zimet GD, Meza HM, Loza ML, Short MB, Succop PA. Uptake of HPV vaccine: demographics, sexual history and values, parenting style, and vaccine attitudes. J Adolesc Health 2008; 43: 23945.
  • 24
    Zimet GD, Liddon N, Rosenthal SL, Lazcano-Ponce E, Allen B. Chapter 24: psychosocial aspects of vaccine acceptability. Vaccine 2006; 24( Suppl 3): S2019.
  • 25
    Kahn JA, Zimet GD, Bernstein DI, Riedesel JM, Lan D, Huang B, Rosenthal SL. Pediatricians' intention to administer human papillomavirus vaccine: the role of practice characteristics, knowledge, and attitudes. J Adolesc Health 2005; 37: 50210.
  • 26
    Riedesel JM, Rosenthal SL, Zimet GD, Bernstein DI, Huang B, Lan D, Kahn JA. Attitudes about human papillomavirus vaccine among family physicians. J Pediatr Adolesc Gynecol 2005; 18: 3918.
  • 27
    Constantine NA, Jerman P. Acceptance of human papillomavirus vaccination among Californian parents of daughters: a representative statewide analysis. J Adolesc Health 2007; 40: 10815.
  • 28
    Davis K, Dickman ED, Ferris D, Dias JK. Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents. J Low Genit Tract Dis 2004; 8: 18894.
  • 29
    Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med 2007; 45: 10714.
  • 30
    Marlow LA, Waller J, Wardle J. Public awareness that HPV is a risk factor for cervical cancer. Br J Cancer 2007; 97: 6914.
  • 31
    Marlow LA, Waller J, Wardle J. Trust and experience as predictors of HPV vaccine acceptance. Hum Vaccin 2007; 3: 1715.
  • 32
    Smith PJ, Chu SY, Barker LE. Children who have received no vaccines: who are they and where do they live? Pediatrics 2004; 114: 18795.